Discover 1,132 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,132
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: New Haven CT, Great Neck NY, Boston MA, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase3, Recruiting
Adaptation and Implementation of Peer Support in Brazil
for
Peer Support
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05842889
Recruiting
New
Pacritinib Effectiveness in Real-world Settings
for
Myelofibrosis (MF)
Location: New Haven CT, Columbus OH, Charleston SC
Sponsor: Swedish Orphan Biovitrum
Sex: All
Age: 18+
Code: NCT07774455
Recruiting
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
for
Solid Tumors
Location: New Haven CT, Hackensack NJ, Los Angeles CA
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05471856
Phase1, Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: New Haven CT, Newark NJ, Montreal, St. Catharines,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT04774159
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: New Haven CT, New York NY, Wynnewood PA, Columbia MD,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06581432
Phase2, Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: New Haven CT, Lake Success NY, The Bronx NY,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
for
Tourette Syndrome in Adolescence
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 10 - 16
Code: NCT05558566
Recruiting
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
for
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes,
Location: New Haven CT, Wilmington DE, Grand Rapids MI,
Sponsor: Washington University School of Medicine
Sex: All
Age: 0 - 21
Code: NCT03128996
Phase1, Phase2, Recruiting
Buprenorphine and Integrated HIV Care Evaluation
for
Opioid-Related Disorders, HIV Infections, AIDS
Location: New Haven CT, New York NY, Providence RI, Baltimore MD,
Sponsor: The New York Academy of Medicine
Sex: All
Age: 18+
Code: NCT00124358
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: New Haven CT, New York NY, Shirley NY, Boston MA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase1, Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: New Haven CT, Mineola NY, The Bronx NY, New York NY,